(Total Views: 557)
Posted On: 02/01/2021 2:39:09 PM
Post# of 154045
Miracule = Molecule + Miracle
There, term has been coined. Not as sexy as Vyrologix or Leronlimab, but it's a try. Of course there's some water company by the same name, but I'm sticking by it.
One quick thought, I'm sure it's been brought up here, but any price action in this name is pure cash as I don't believe any platform allows leverage with OTC. You can expect at least 2-4x more volatility after uplisting. The uplist will, at the very least, lead to a price spike not just because of the benefits of the uplist but because of the leverage sugar rush as well. How sticky that sugar boost is will yet tbd. Pun intended.
At least if you are an investor, the volatility is completely irrelevant as you wait for your price point to be hit, 1-3-5-10 years from now, however it gets there.
Invisioner's post is a reminder though, that as much as this stock will, at points, feel like a game for some (GME, TSLA, etc.), this is a real product with real life or death implications for many. Investor gains will always be second to that, always.
There, term has been coined. Not as sexy as Vyrologix or Leronlimab, but it's a try. Of course there's some water company by the same name, but I'm sticking by it.
One quick thought, I'm sure it's been brought up here, but any price action in this name is pure cash as I don't believe any platform allows leverage with OTC. You can expect at least 2-4x more volatility after uplisting. The uplist will, at the very least, lead to a price spike not just because of the benefits of the uplist but because of the leverage sugar rush as well. How sticky that sugar boost is will yet tbd. Pun intended.
At least if you are an investor, the volatility is completely irrelevant as you wait for your price point to be hit, 1-3-5-10 years from now, however it gets there.
Invisioner's post is a reminder though, that as much as this stock will, at points, feel like a game for some (GME, TSLA, etc.), this is a real product with real life or death implications for many. Investor gains will always be second to that, always.
(4)
(0)
